456 related articles for article (PubMed ID: 35230692)
1. Molecular Profiling of Liquid Biopsies for Precision Oncology.
Gonzalez-Kozlova EE
Adv Exp Med Biol; 2022; 1361():235-247. PubMed ID: 35230692
[TBL] [Abstract][Full Text] [Related]
2. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.
Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J
Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy: current technology and clinical applications.
Nikanjam M; Kato S; Kurzrock R
J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
[TBL] [Abstract][Full Text] [Related]
4. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
Moldogazieva NT; Zavadskiy SP; Terentiev AA
Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
[TBL] [Abstract][Full Text] [Related]
5. Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection.
Cani AK; Dolce EM; Darga EP; Hu K; Liu CJ; Pierce J; Bradbury K; Kilgour E; Aung K; Schiavon G; Carroll D; Carr TH; Klinowska T; Lindemann J; Marshall G; Rowlands V; Harrington EA; Barrett JC; Sathiyayogan N; Morrow C; Sero V; Armstrong AC; Baird R; Hamilton E; Im SA; Jhaveri K; Patel MR; Dive C; Tomlins SA; Udager AM; Hayes DF; Paoletti C
Mol Oncol; 2022 May; 16(10):1969-1985. PubMed ID: 34866317
[TBL] [Abstract][Full Text] [Related]
6. Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers.
Addanki S; Meas S; Sarli VN; Singh B; Lucci A
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887191
[TBL] [Abstract][Full Text] [Related]
7. Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine.
Bao Y; Zhang D; Guo H; Ma W
Cancer Sci; 2024 Apr; 115(4):1060-1072. PubMed ID: 38308498
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor DNA: current challenges for clinical utility.
Dang DK; Park BH
J Clin Invest; 2022 Jun; 132(12):. PubMed ID: 35703177
[TBL] [Abstract][Full Text] [Related]
9. The Different Facets of Liquid Biopsy: A Kaleidoscopic View.
Eslami-S Z; Cortés-Hernández LE; Cayrefourcq L; Alix-Panabières C
Cold Spring Harb Perspect Med; 2020 Jun; 10(6):. PubMed ID: 31548226
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsies.
Lianidou E; Pantel K
Genes Chromosomes Cancer; 2019 Apr; 58(4):219-232. PubMed ID: 30382599
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy in breast cancer: A comprehensive review.
Alimirzaie S; Bagherzadeh M; Akbari MR
Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
[TBL] [Abstract][Full Text] [Related]
12. The potential of liquid biopsy in the management of cancer patients.
Markou A; Tzanikou E; Lianidou E
Semin Cancer Biol; 2022 Sep; 84():69-79. PubMed ID: 35331850
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
[TBL] [Abstract][Full Text] [Related]
14. Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers.
Madueke I; Lee RJ; Miyamoto DT
Urol Clin North Am; 2023 Feb; 50(1):109-114. PubMed ID: 36424075
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of cancer patients via next-generation sequencing of patient-derived circulating tumor cells and tumor DNA.
Onidani K; Shoji H; Kakizaki T; Yoshimoto S; Okaya S; Miura N; Sekikawa S; Furuta K; Lim CT; Shibahara T; Boku N; Kato K; Honda K
Cancer Sci; 2019 Aug; 110(8):2590-2599. PubMed ID: 31169336
[TBL] [Abstract][Full Text] [Related]
16. Liquid biopsy: possibilities and limitations in uro-oncology.
López-Guerrero JA; Pastor-Navarro B; Claramunt-Alonso R; García-Flores M; Rubio-Briones J
Arch Esp Urol; 2022 Mar; 75(2):203-214. PubMed ID: 35332890
[TBL] [Abstract][Full Text] [Related]
17. Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine.
Rossi G; Ignatiadis M
Cancer Res; 2019 Jun; 79(11):2798-2804. PubMed ID: 31109952
[TBL] [Abstract][Full Text] [Related]
18. Liquid biopsy for precision diagnostics and therapeutics.
Anitha K; Posinasetty B; Naveen Kumari K; Chenchula S; Padmavathi R; Prakash S; Radhika C
Clin Chim Acta; 2024 Feb; 554():117746. PubMed ID: 38151071
[TBL] [Abstract][Full Text] [Related]
19. Cell-free circulating tumor DNA supplementing tissue biopsies for identification of targetable mutations: Implications for precision medicine and considerations for reconciling results.
Hicks JK; Saller J; Wang E; Boyle T; Gray JE
Lung Cancer; 2017 Sep; 111():135-138. PubMed ID: 28838384
[TBL] [Abstract][Full Text] [Related]
20. Application of liquid biopsy in precision medicine: opportunities and challenges.
Wang J; Chang S; Li G; Sun Y
Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
